Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL-001 Ophthalmic Injection in wet age-related macular degeneration (wAMD)
CTR20231950Phase 2Completed
- Sponsor
- Anlong Bio
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AL001 in exudative macular degeneration, sponsored by Anlong Bio. Started Jul 2023; status: completed.
02
Drugs
AL001
03
Conditions
exudative macular degeneration
Beyond the preview
Go deeper on CTR20231950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231950.